Evidence map›Paper›PMID 31065624›Full record

ArticleJournal of pancreatic cancer2019

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Anteneh A Tesfaye, Hongkun Wang, Marion L Hartley, Aiwu Ruth He, Louis Weiner, Nina Gabelia, Lana Kapanadze, Muhammad Shezad, Jonathan R Brody, John L Marshall and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pancreatic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer.International journal of molecular sciences · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Anteneh A TesfayeKarmanos Cancer Institute, Wayne State University, Detroit, Michigan.
Hongkun WangLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Marion L HartleyLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Aiwu Ruth HeLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Louis WeinerLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Nina GabeliaLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Lana KapanadzeLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Muhammad ShezadLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Jonathan R BrodyDepartment of Surgery, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
John L MarshallLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Michael J PishvaianLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Georgetown University · USSidney Kimmel Cancer Center · USWayne State University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapymetastatic pancreatic cancermolecular testing

Identifiers

PMID31065624
PMCPMC6503449
OpenAlexW2942540362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.